While many seasonal illnesses are associated with symptoms such as nasal blockage and mucous production, COVID-19 lacks these indicators. Physicians are now recognizing that the loss of taste and smell could be a key indicator for the virus.
As the coronavirus surges across the globe, diagnostic testing comes into its own, as researchers unite to confront, delay and stop its spread. In the absence of either proven effective therapy or a vaccine, diagnostic testing becomes a valuable tool.
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
The development of a paper-based, point-of-care diagnostic test may enable clinicians to rapidly detect bacterial infections and their antibiotic susceptibility with a simple colorimetric readout.
This opinion piece looks at the impact a precision (or personalized) medicine approach could have in sepsis, including early and accurate microbiologic diagnosis, determining the host immune response signature and assessing individual response to treatment.
Precision medicine is an approach to patient care that aims for the right intervention, in the right patient, at the right time – but what impact could this have on the treatment of infectious diseases? We asked Mathias Pletz about this approach to treatment, the research he’s directing at his institute and what the challenges are in this field.
The WHO have updated their recommendations on HIV testing in order to try and expand treatment coverage and reach the people living with HIV who are not yet diagnosed.
For the first time a team of researchers have discovered clear signs of enterovirus in acute flaccid myelitis patients, strongly suggesting that the disease is viral.
A novel phage-based blood assay has demonstrated its potential for identifying people at high-risk of developing tuberculosis, in addition to diagnosing established cases.
In this interview we speak to David Padley from the National Institute for Biological Standards and Control about his recent poster ‘Point-of-Care testing for HIV: specialist quality control materials are a necessity’, presented at ECCMID 2019.
